Literature DB >> 34845016

Recognition of the antigen-presenting molecule MR1 by a Vδ3+ γδ T cell receptor.

Michael T Rice1,2,3, Anouk von Borstel1,2, Priyanka Chevour1,2, Wael Awad1,2, Lauren J Howson1,2, Dene R Littler1,2, Nicholas A Gherardin4,5, Jérôme Le Nours1,2,3, Edward M Giles6,7, Richard Berry1,2,3, Dale I Godfrey4,5, Martin S Davey8,2,3, Jamie Rossjohn8,2,3,9, Benjamin S Gully8,2,3.   

Abstract

Unlike conventional αβ T cells, γδ T cells typically recognize nonpeptide ligands independently of major histocompatibility complex (MHC) restriction. Accordingly, the γδ T cell receptor (TCR) can potentially recognize a wide array of ligands; however, few ligands have been described to date. While there is a growing appreciation of the molecular bases underpinning variable (V)δ1+ and Vδ2+ γδ TCR-mediated ligand recognition, the mode of Vδ3+ TCR ligand engagement is unknown. MHC class I-related protein, MR1, presents vitamin B metabolites to αβ T cells known as mucosal-associated invariant T cells, diverse MR1-restricted T cells, and a subset of human γδ T cells. Here, we identify Vδ1/2- γδ T cells in the blood and duodenal biopsy specimens of children that showed metabolite-independent binding of MR1 tetramers. Characterization of one Vδ3Vγ8 TCR clone showed MR1 reactivity was independent of the presented antigen. Determination of two Vδ3Vγ8 TCR-MR1-antigen complex structures revealed a recognition mechanism by the Vδ3 TCR chain that mediated specific contacts to the side of the MR1 antigen-binding groove, representing a previously uncharacterized MR1 docking topology. The binding of the Vδ3+ TCR to MR1 did not involve contacts with the presented antigen, providing a basis for understanding its inherent MR1 autoreactivity. We provide molecular insight into antigen-independent recognition of MR1 by a Vδ3+ γδ TCR that strengthens an emerging paradigm of antibody-like ligand engagement by γδ TCRs.

Entities:  

Keywords:  MR1; structural immunology; γδTCR

Mesh:

Substances:

Year:  2021        PMID: 34845016      PMCID: PMC8694053          DOI: 10.1073/pnas.2110288118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  69 in total

1.  Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines.

Authors:  Timothy M McPhillips; Scott E McPhillips; Hsiu-Ju Chiu; Aina E Cohen; Ashley M Deacon; Paul J Ellis; Elspeth Garman; Ana Gonzalez; Nicholas K Sauter; R Paul Phizackerley; S Michael Soltis; Peter Kuhn
Journal:  J Synchrotron Radiat       Date:  2002-11-01       Impact factor: 2.616

2.  Diversity of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential Antigen Recognition.

Authors:  Nicholas A Gherardin; Andrew N Keller; Rachel E Woolley; Jérôme Le Nours; David S Ritchie; Paul J Neeson; Richard W Birkinshaw; Sidonia B G Eckle; John N Waddington; Ligong Liu; David P Fairlie; Adam P Uldrich; Daniel G Pellicci; James McCluskey; Dale I Godfrey; Jamie Rossjohn
Journal:  Immunity       Date:  2016-01-12       Impact factor: 31.745

3.  Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22.

Authors:  Erin J Adams; Yueh-Hsiu Chien; K Christopher Garcia
Journal:  Science       Date:  2005-04-08       Impact factor: 47.728

Review 4.  γδ-T cells: an unpolished sword in human anti-infection immunity.

Authors:  Jian Zheng; Yinping Liu; Yu-Lung Lau; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2012-10-15       Impact factor: 11.530

5.  The molecular basis underpinning the potency and specificity of MAIT cell antigens.

Authors:  Wael Awad; Geraldine J M Ler; Weijun Xu; Andrew N Keller; Jeffrey Y W Mak; Xin Yi Lim; Ligong Liu; Sidonia B G Eckle; Jérôme Le Nours; James McCluskey; Alexandra J Corbett; David P Fairlie; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2020-03-02       Impact factor: 25.606

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment.

Authors:  K Deusch; F Lüling; K Reich; M Classen; H Wagner; K Pfeffer
Journal:  Eur J Immunol       Date:  1991-04       Impact factor: 5.532

8.  T-cell activation by transitory neo-antigens derived from distinct microbial pathways.

Authors:  Alexandra J Corbett; Sidonia B G Eckle; Richard W Birkinshaw; Ligong Liu; Onisha Patel; Jennifer Mahony; Zhenjun Chen; Rangsima Reantragoon; Bronwyn Meehan; Hanwei Cao; Nicholas A Williamson; Richard A Strugnell; Douwe Van Sinderen; Jeffrey Y W Mak; David P Fairlie; Lars Kjer-Nielsen; Jamie Rossjohn; James McCluskey
Journal:  Nature       Date:  2014-04-02       Impact factor: 49.962

9.  Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire.

Authors:  C M Parker; V Groh; H Band; S A Porcelli; C Morita; M Fabbi; D Glass; J L Strominger; M B Brenner
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

10.  Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance.

Authors:  Martin S Davey; Carrie R Willcox; Stephen P Joyce; Kristin Ladell; Sofya A Kasatskaya; James E McLaren; Stuart Hunter; Mahboob Salim; Fiyaz Mohammed; David A Price; Dmitriy M Chudakov; Benjamin E Willcox
Journal:  Nat Commun       Date:  2017-03-01       Impact factor: 14.919

View more
  6 in total

1.  CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cells.

Authors:  Michael N T Souter; Wael Awad; Shihan Li; Troi J Pediongco; Bronwyn S Meehan; Lucy J Meehan; Zehua Tian; Zhe Zhao; Huimeng Wang; Adam Nelson; Jérôme Le Nours; Yogesh Khandokar; T Praveena; Jacinta Wubben; Jie Lin; Lucy C Sullivan; George O Lovrecz; Jeffrey Y W Mak; Ligong Liu; Lyudmila Kostenko; Katherine Kedzierska; Alexandra J Corbett; David P Fairlie; Andrew G Brooks; Nicholas A Gherardin; Adam P Uldrich; Zhenjun Chen; Jamie Rossjohn; Dale I Godfrey; James McCluskey; Daniel G Pellicci; Sidonia B G Eckle
Journal:  J Exp Med       Date:  2022-08-26       Impact factor: 17.579

Review 2.  γδ T, NKT, and MAIT Cells During Evolution: Redundancy or Specialized Functions?

Authors:  Christelle Harly; Jacques Robert; Francois Legoux; Olivier Lantz
Journal:  J Immunol       Date:  2022-07-15       Impact factor: 5.426

3.  Myeloid cell tropism enables MHC-E-restricted CD8+ T cell priming and vaccine efficacy by the RhCMV/SIV vaccine.

Authors:  Scott G Hansen; Meaghan H Hancock; Daniel Malouli; Emily E Marshall; Colette M Hughes; Kurt T Randall; David Morrow; Julia C Ford; Roxanne M Gilbride; Andrea N Selseth; Renee Espinosa Trethewy; Lindsey M Bishop; Kelli Oswald; Rebecca Shoemaker; Brian Berkemeier; William J Bosche; Michael Hull; Lorna Silipino; Michael Nekorchuk; Kathleen Busman-Sahay; Jacob D Estes; Michael K Axthelm; Jeremy Smedley; Danica Shao; Paul T Edlefsen; Jeffrey D Lifson; Klaus Früh; Jay A Nelson; Louis J Picker
Journal:  Sci Immunol       Date:  2022-06-17

4.  Atypical sideways recognition of CD1a by autoreactive γδ T cell receptors.

Authors:  Marcin Wegrecki; Tonatiuh A Ocampo; Sachith D Gunasinghe; Anouk von Borstel; Shin Yi Tin; Josephine F Reijneveld; Thinh-Phat Cao; Benjamin S Gully; Jérôme Le Nours; D Branch Moody; Ildiko Van Rhijn; Jamie Rossjohn
Journal:  Nat Commun       Date:  2022-07-05       Impact factor: 17.694

5.  3D structures inferred from cDNA clones identify the CD1D-Restricted γδ T cell receptor in dromedaries.

Authors:  Giovanna Linguiti; Vincenzo Tragni; Ciro Leonardo Pierri; Serafina Massari; Marie-Paule Lefranc; Rachele Antonacci; Salvatrice Ciccarese
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

Review 6.  Intracellular radar: Understanding γδ T cell immune surveillance and implications for clinical strategies in oncology.

Authors:  Anne B C Cherry; Nicholas A Gherardin; Hafiz I Sikder
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.